The potential mechanism linking serum FFAs with MASLD progression involves FFA-induced hepatocellular apoptosis and injury by activating the pro-apoptotic protein Bax in a c-Jun N-terminal kinase-dependent manner [37]. This evidence concerns the gene BAX and metabolic dysfunction-associated steatotic liver disease.